Cargando…
Efficacy and safety of intensity-modulated radiotherapy alone versus intensity-modulated radiotherapy plus chemotherapy for treatment of intermediate-risk nasopharyngeal carcinoma
BACKGROUND: This study directs to evaluate the efficacy and safety of intensity-modulated radiotherapy (IMRT) alone versus IMRT plus chemotherapy in intermediate-risk NPC (stage II and T(3)N(0)M(0)). METHODS: A total of 124 patients with stage II and T(3)N(0)M(0) NPC were pair-matched (1:1 ratio) to...
Autores principales: | Aftab, Omer, Liao, Shufang, Zhang, Rongjun, Tang, Nan, Luo, Meiqing, Zhang, Bin, Shahi, Sanjeev, Rai, Raju, Ali, Jazib, Jiang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074987/ https://www.ncbi.nlm.nih.gov/pubmed/32178698 http://dx.doi.org/10.1186/s13014-020-01508-4 |
Ejemplares similares
-
Effect of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy alone in nasopharyngeal carcinoma
por: OuYang, Pu-Yun, et al.
Publicado: (2016) -
Analysis of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma
por: Wu, Shihai, et al.
Publicado: (2020) -
Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma
por: Liu, You-Ping, et al.
Publicado: (2019) -
Concurrent chemoradiotherapy versus radiotherapy alone for locoregionally advanced nasopharyngeal carcinoma in the era of intensity-modulated radiotherapy: a meta-analysis
por: He, Yan, et al.
Publicado: (2018) -
Intensity-modulated radiotherapy plus nimotuzumab with or without concurrent chemotherapy for patients with locally advanced nasopharyngeal carcinoma
por: Huang, Jianfeng, et al.
Publicado: (2017)